Korea:229000.KQ News & Press Release Distribution

Korea:229000.KQ

Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test

SEOUL, South Korea, Oct. 12, 2023 /PRNewswire/ -- Gencurix , a cancer molecular diagnostics company, has obtained approval from the Australian Government (The Department of Health and Aged Care, Therapeutic Goods Administration) for its Droplex POLE Mutati...

2023-10-12 06:00 2013

Gencurix Obtains Approval for Companion Diagnostic of Digital PCR-based EGFR Mutation Test

SEOUL, South Korea, June 13, 2023 /PRNewswire/ -- Gencurix , a leading cancer molecular diagnostics company, has obtained approval from the Korean Ministry of Food and Drug Safety for its Droplex EGFR Mutation Test v2. This product is a companion diagnosti...

2023-06-14 09:00 2057

Gencurix Announces Clinical Research Results At ASCO Demonstrating Outstanding Performance of GenesWellBCT Compared to Global Best-Selling Test, OncotypeDX

SEOUL, South Korea, June 7, 2023 /PRNewswire/ -- Gencurix an nounced the release of clinical research results comparing the accuracy of its breast cancer prognostic test, GenesWellBCT, with OncotypeDX, the globally top-s...

2023-06-07 12:29 2744

Gencurix Announces Clinical Research Results At ASCO 2023 Demonstrating Outstanding Performance of GenesWell BCT, the Company's Breast Cancer Prognostic Test, Compared to Global Best-Selling Test, OncotypeDX

SEOUL, South Korea, June 4, 2023 /PRNewswire/ -- Gencurix (KOSDAQ #229000), a leading provider of cancer molecular diagnostics, announced the release of clinical research results directly comparing the accuracy of its breast cancer prognostic test, GenesW...

2023-06-05 14:37 2755

Gencurix announced Korean and Japanese cancer patients' 15-year follow-up prognostic test clinical results

SEOUL, South Korea, May 9, 2023 /PRNewswire/ -- Gencurix announced clinical results of its prognostic test for breast cancer patients at the Global Breast Cancer Conference 2023. The study, 'Long-term prognostic value of GenesWellBCT score in Asian women ...

2023-05-10 08:00 2671

Korea:229000.KQ

Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test

Gencurix Obtains Approval for Companion Diagnostic of Digital PCR-based EGFR Mutation Test

Gencurix Announces Clinical Research Results At ASCO Demonstrating Outstanding Performance of GenesWellBCT Compared to Global Best-Selling Test, OncotypeDX

Gencurix Announces Clinical Research Results At ASCO 2023 Demonstrating Outstanding Performance of GenesWell BCT, the Company's Breast Cancer Prognostic Test, Compared to Global Best-Selling Test, OncotypeDX

Gencurix announced Korean and Japanese cancer patients' 15-year follow-up prognostic test clinical results

Week's Top Stories

Most Reposted

Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution

Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival

DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution

Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans

Sobot Introduces its All-in-One Solution at GITEX Global 2024

Most Read

Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution

XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific

XTEP's First Mono Store in Malaysia Comes to Puchong

Asia Sustainable Aviation Fuel Association Launches to Transform Policy, Markets and Investment for Sustainable Aviation Fuel Across Asia

DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam